ArticleInternational journal of molecular sciences2020

Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19.

Sara Schumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.